Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

XEPAMET TABLETS 200 mg - HSA Drug Approval Details

Approvals/HSA/XEPAMET TABLETS 200 mg

Approved

THERAPEUTIC

XEPAMET TABLETS 200 mg

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD🇸🇬 Health Sciences Authority

Approval Date: Feb 23, 1995
Approval ID: 5df6c8986d5249d6
Company: XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Type: Therapeutic

Approval Details

Approval Id: 5df6c8986d5249d6
Drug Name: XEPAMET TABLETS 200 mg
Product Name: XEPAMET TABLETS 200 mg
Approval Number: SIN08029P
Approval Date: 1995-02-23
Registrant: APEX PHARMA MARKETING PTE. LTD.
Licence Holder: APEX PHARMA MARKETING PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: A02BA01
Atc Item Name: cimetidine
Pharma Manufacturer Name: APEX PHARMA MARKETING PTE. LTD.
Company Detail Path: /organization/apex-pharma-marketing-pte-ltd

Active Ingredients

CIMETIDINE

200 mg

CIMETIDINE

200 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 23, 1995

Approval ID

5df6c8986d5249d6

Type

Therapeutic

Back to HSA Approvals